Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Back

EHRA Premium Access

Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Session: Moderated ePosters 11: AF: stroke and anticoagulation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor M. Proietti (Milan, IT)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)

11 presentations

1 follower

5 more presentations in this session

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Assistant Professor Y. Baek (Incheon, KR)

Access

Abstract

Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Doctor A. Berkovitch (Ramat Gan, IL)

Access

Abstract

Slides

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Speaker: Doctor W. McIntyre (Hamilton, CA)

Access

Abstract

Slides

Prediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation: Comparison of CHA2DS2-VASc and GARFIELD-AF Stroke Risk Scores

Speaker: Doctor M. Proietti (Milan, IT)

Access

Abstract

Slides

Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure

Speaker: Doctor S. Bordignon (Frankfurt, DE)

Access

Abstract

Slides

Access the full session

Moderated ePosters 11: AF: stroke and anticoagulation

Speakers: Associate Professor M. Proietti, Assistant Professor Y. Baek, Doctor A. Berkovitch, Doctor W. McIntyre, Doctor M. Proietti...

Access

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources